therapies for serious rare and life-threatening diseases with critical unmet medical need
Active 2019–2023.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2023 | BURRELL INTERNATIONAL GROUP LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$20,000 | |
| 2023 | BURRELL INTERNATIONAL GROUP LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | |
| 2023 | BURRELL INTERNATIONAL GROUP LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | |
| 2023 | BURRELL INTERNATIONAL GROUP LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | |
| 2022 | BURRELL INTERNATIONAL GROUP LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2022 | BURRELL INTERNATIONAL GROUP LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | |
| 2022 | BURRELL INTERNATIONAL GROUP LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | |
| 2022 | BURRELL INTERNATIONAL GROUP LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | |
| 2021 | BURRELL INTERNATIONAL GROUP LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2021 | BURRELL INTERNATIONAL GROUP LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 |
| Firm | Filings | Amount |
|---|---|---|
| BURRELL INTERNATIONAL GROUP LLC | 21 | $380,000 |
| Issue | Activities |
|---|---|
| Pharmacy | 21 |
| Health Issues | 1 |